ZJ43 is a potent NAAG peptidase inhibitor, with an IC 50 of 2.4 nM and a K i of 0.8 nM. ZJ43 sufficiently activates group II mGluR and reduces some of the behavioral effects of PCP. ZJ43 shows an analgesic effect in neuropathic and inflammatory and pain models.